Conference Coverage

Simplify cardiac risk assessment for rheumatologic conditions

Publish date: June 14, 2016

 

AT THE EULAR 2016 CONGRESS

References

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Pages

Recommended Reading

Biosimilar program reshapes FDA’s objectivity
MDedge Family Medicine
Once-daily tofacitinib formulation gets FDA clearance for RA
MDedge Family Medicine
Expert advises how to use shingles vaccine in rheumatology patients
MDedge Family Medicine
Registry study adds evidence for use of DMARD combo first in early RA
MDedge Family Medicine
Analysis provides key questions – and answers – regarding future of JAK inhibitors for RA
MDedge Family Medicine
Early RA remission more unstable in the presence of foot synovitis
MDedge Family Medicine
Inflectra becomes first FDA-approved biosimilar for inflammatory diseases
MDedge Family Medicine
Make informed treatment decisions about biosimilars
MDedge Family Medicine
Hydroxychloroquine, abatacept linked with reduced type 2 diabetes
MDedge Family Medicine
VIDEO: Smoking, excess weight hinder sustained remission in early RA
MDedge Family Medicine